Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (the “Company” or “Chemesis”), is pleased to announce that it has closed the previously announced debenture unit offering with strategic investors for aggregate gross proceeds to the Company of CDN $2,000,000 (the “Offering”).
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the "Company") today provided a Fundamental Change Notice, Notice of Right to Convert, Notice of Make-Whole Fundamental Change and Related Conversion Rate Adjustment, and Offer to Repurchase for Cash (the "Notice") to holders of its C$600,000,000 aggregate principal amount of 4.25% Convertible Senior Notes Due 2023 (the "Notes"), pursuant to the Indenture, dated June 20, 2018, among the Company, GLAS Trust Company LLC, as U.S.
Tree of Knowledge International Corp. (CSE: TOKI; OTC PINK: TRKWF) (the "Company" or "TOK") (formerly Courtland Capital Inc.) wishes to provide an update on a number of corporate and strategic matters as the landscape has evolved quickly since the Company's listing on the Canadian Securities Exchange at the beginning of summer earlier this year (July 9, 2018).
Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, is pleased to announce the completed sale of Trauma Healing Centers (THC) to Harvest Medicine Inc. ("HMed" or "Harvest Medicine"), a medical cannabis clinic group located in Edmonton and Calgary, Alberta. Harvest Medicine is a wholly-owned subsidiary of VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF).
Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that the Company has elected to exercise its right under the indenture (the "Indenture") governing the Company's 6.0% unsecured convertible debentures due November 28, 2022 (the "Debentures") to convert (the "Conversion") all of the principal amount outstanding of the remaining Debentures up to November 16, 2018 into common shares of the Company (the "Common Shares").
Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced it has received the necessary compliance verification from Health Canada to release for sale its innovative, high-potency, vape-ready CBD oil product line. Launched today under the brand Aurora Cloud, the first products released contain over 550mg of CBD and less than 30mg of THC, making them the only vape-ready CBD products legally available in Canada.
The California cannabis market is one of the most exciting opportunities in the world and we have been closely monitoring this burgeoning market.
Although many investors have been focused on the Canadian market, we believe the California cannabis market is in the early innings of a major growth cycle and presents an opportunity that needs to be monitored.
Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, is pleased to announce the closing of its strategic investment in convertible secured debentures (the "Debentures"), to be purchased in three tranches and valued in the aggregate at $10 million, of Hyasynth Biologicals Inc.
Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQX:OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, today announced that it has chosen to include its award-winning sativa flower, Wabanaki, in the AHLOT Cannabis Collections: Discovery Series Vol. 1™.
Namaste Technologies Inc. ("Namaste" or the "Company") (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) is pleased to announce that further to its July 23(rd) news release, the Company intends to continue to pursue the listing of its common shares on the NASDAQ Capital Market ("NASDAQ"). Due to Company developments and a recent increase in its share price, the Company is now closer to meeting the requirements to list on NASDAQ.